FDA.reportPublic FDA data

bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG Ophthalmic Ointment [Neo-Polycin]

RxCUI
1117090
RxNorm name
bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG Ophthalmic Ointment [Neo-Polycin]
Display name
NEO-POLYCIN (Ophthalmic)
Full name
bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG Ophthalmic Ointment [Neo-Polycin]
Term type
SBD
Status
Active
Strength
0.4-0.0035-10 var units
Dose form
Ointment
Route
Ophthalmic
Updated
2026-06-16 07:09:44

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
092011
Active start
092011
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
bacitracin zinc0.4 UNT / 1 MGbacitracinbacitracin
neomycin sulfate0.0035 MG / 1 MGneomycinneomycin
polymyxin B sulfate10 UNT / 1 MGpolymyxin Bpolymyxin B

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Ophthalmic Ointment91344

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
bacitracin1291
neomycin7299
polymyxin B8536

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRNeo-Polycin (bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 10,000 UNT per GM) Ophthalmic OintmentNAMES
RxNorm Namebacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG Ophthalmic Ointment [Neo-Polycin]NAMES
RxNorm SynonymNeo-Polycin (bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 10,000 UNT per GM) Ophthalmic OintmentNAMES
TTYSBDATTRIBUTES
RxCUI1117090CODES
MMSL_CODEBD764CODES

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
00574425035rxnav_ndcsyes
42254030235rxnav_historical
48102000635rxnav_historical
50090224000rxnav_historical

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
23764466-adbe-4c9c-be60-3b09458d634ebacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG Ophthalmic Ointment [Neo-Polycin]SBD1NEO-POLYCIN20120926
23764466-adbe-4c9c-be60-3b09458d634eNeo-Polycin (bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 10,000 UNT per GM) Ophthalmic OintmentSY1NEO-POLYCIN20120926
23764466-adbe-4c9c-be60-3b09458d634eNeo-Polycin 400 UNT / 3.5 MG / 10,000 UNT per GM Ophthalmic OintmentPSN1NEO-POLYCIN20120926

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
23764466-adbe-4c9c-be60-3b09458d634eNEO-POLYCINRebel Distributors Corp | PSS World Medical, Inc. | STAT RX USA LLC | Dispensing Solutions, Inc. | SCRIPT PAK | Keltman Pharmaceuticals, Inc. | Rebel Distirbutors Corp.20120926

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCS01AAAntibioticsATC1-4polymyxin B
ATCA07AAAntibioticsATC1-4polymyxin B
ATCS01AAAntibioticsATC1-4neomycin
ATCR02ABAntibioticsATC1-4neomycin
ATCA07AAAntibioticsATC1-4neomycin
ATCS01AAAntibioticsATC1-4bacitracin
ATCR02ABAntibioticsATC1-4bacitracin
ATCS03AAAntiinfectivesATC1-4polymyxin B
ATCS02AAAntiinfectivesATC1-4polymyxin B
ATCS03AAAntiinfectivesATC1-4neomycin
ATCS02AAAntiinfectivesATC1-4neomycin
ATCB05CAAntiinfectivesATC1-4neomycin
ATCA01ABAntiinfectives and antiseptics for local oral treatmentATC1-4neomycin
ATCJ01GBOther aminoglycosidesATC1-4neomycin
ATCJ01XXOther antibacterialsATC1-4bacitracin
ATCD06AXOther antibiotics for topical useATC1-4bacitracin
ATCD06AXOther antibiotics for topical useATC1-4neomycin
ATCJ01XBPolymyxinsATC1-4polymyxin B
FDASPLD000617AminoglycosidesCHEMhas_chemical_structureneomycin
FDASPLN0000175477Aminoglycoside AntibacterialEPChas_epcneomycin
FDASPLN0000175499Polymyxin-class AntibacterialEPChas_epcpolymyxin B
FDASPLN0000008479Decreased Cell Wall Synthesis & RepairPEhas_pebacitracin
MEDRTD001414BacitracinCHEMhas_ingredientbacitracin
MEDRTD009355NeomycinCHEMhas_ingredientneomycin
MEDRTD011112Polymyxin BCHEMhas_ingredientpolymyxin B
MEDRTD016470BacteremiaDISEASEmay_treatpolymyxin B
MEDRTD001424Bacterial InfectionsDISEASEmay_preventneomycin
MEDRTD004342Drug HypersensitivityDISEASEci_withbacitracin
MEDRTD004342Drug HypersensitivityDISEASEci_withpolymyxin B
MEDRTD004342Drug HypersensitivityDISEASEci_withneomycin
MEDRTD004653EmpyemaDISEASEmay_treatbacitracin
MEDRTD004761Enterocolitis, PseudomembranousDISEASEmay_treatbacitracin
MEDRTD004927Escherichia coli InfectionsDISEASEmay_treatpolymyxin B
MEDRTD004927Escherichia coli InfectionsDISEASEmay_treatneomycin
MEDRTD015818Eye Infections, BacterialDISEASEmay_treatpolymyxin B
MEDRTD015818Eye Infections, BacterialDISEASEmay_treatbacitracin
MEDRTD005767Gastrointestinal DiseasesDISEASEmay_treatpolymyxin B
MEDRTD006192Haemophilus InfectionsDISEASEmay_treatpolymyxin B
MEDRTD006501Hepatic EncephalopathyDISEASEmay_treatneomycin
MEDRTD015212Inflammatory Bowel DiseasesDISEASEci_withneomycin
MEDRTD007415Intestinal ObstructionDISEASEci_withneomycin
MEDRTD007674Kidney DiseasesDISEASEci_withbacitracin
MEDRTD007710Klebsiella InfectionsDISEASEmay_treatpolymyxin B
MEDRTD016920Meningitis, BacterialDISEASEmay_treatpolymyxin B
MEDRTD010032Otitis ExternaDISEASEmay_treatpolymyxin B
MEDRTD011014PneumoniaDISEASEmay_treatbacitracin
MEDRTD011552Pseudomonas InfectionsDISEASEmay_treatpolymyxin B
MEDRTD012871Skin DiseasesDISEASEmay_treatpolymyxin B
MEDRTD017192Skin Diseases, BacterialDISEASEmay_treatbacitracin
MEDRTD017192Skin Diseases, BacterialDISEASEmay_preventbacitracin
MEDRTD017192Skin Diseases, BacterialDISEASEmay_treatneomycin
MEDRTD018461Soft Tissue InfectionsDISEASEmay_treatpolymyxin B
MEDRTD013203Staphylococcal InfectionsDISEASEmay_treatbacitracin
MEDRTD013290Streptococcal InfectionsDISEASEmay_treatbacitracin
MEDRTD001745Urinary Bladder DiseasesDISEASEmay_treatpolymyxin B
MEDRTD014947Wounds and InjuriesDISEASEmay_treatpolymyxin B
MEDRTN0000000226Acid-Base ActivityMOAhas_moapolymyxin B
MEDRTN0000009954Cell Membrane Fusion Complex InteractionsMOAhas_moabacitracin
MEDRTN0000000227Cholinergic Nicotinic AntagonistsMOAci_moapolymyxin B
MEDRTN0000000163Enzyme InteractionsMOAhas_moabacitracin
MEDRTN0000000150Protein Synthesis InhibitorsMOAhas_moaneomycin
MEDRTN0000008346Cellular Structure AlterationPEhas_pepolymyxin B
MEDRTN0000008479Decreased Cell Wall Synthesis & RepairPEhas_pebacitracin
MEDRTN0000008841Decreased Protein SynthesisPEhas_peneomycin
MEDRTN0000008953Decreased Striated Muscle ContractionPEci_pepolymyxin B

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.4 UNT/MG / 0.0035 MG/MG / 10 UNT/MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
ATTRIBUTESTTYSBD
CODESMMSL_CODEBD764
CODESRxCUI1117090
NAMESPrescribable SynonymNeo-Polycin 400 UNT / 3.5 MG / 10,000 UNT per GM Ophthalmic Ointment
NAMESRXNAV_STRNeo-Polycin (bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 10,000 UNT per GM) Ophthalmic Ointment
NAMESRxNorm Namebacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG Ophthalmic Ointment [Neo-Polycin]
NAMESRxNorm SynonymNeo-Polycin (bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 10,000 UNT per GM) Ophthalmic Ointment
SOURCESSourceGold Standard Alchemy
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon